Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

XORTX Therapeutics Inc V.XRTX

Alternate Symbol(s):  XRTX

XORTX Therapeutics Inc. is a Canada-based late-stage clinical pharmaceutical company. The Company develops therapies to treat progressive kidney disease modulated by aberrant purine and uric acid metabolism in orphan disease indications, such as autosomal dominant polycystic kidney disease (ADPKD), as well as type 2 diabetic nephropathy (T2DN) and fatty liver disease. It is working to advance its clinical development stage products that target aberrant purine metabolism and xanthine oxidase to decrease or inhibit production of uric acid. The Company has three product development programs: XRx-008, which is a program for the treatment of ADPKD; XRx-101, which is a program to treat acute kidney injury (AKI) associated with respiratory virus infection, AKI and associated health consequences, and XRx- 225, a program for the treatment of T2DN. The Company's XRx-008 program is designed for longer term stable chronic oral dosing of xanthine oxidase inhibitors.


TSXV:XRTX - Post by User

Post by KOkidneydiseaseon Apr 05, 2023 5:33pm
279 Views
Post# 35381986

XORTX is on the move for good reason.

XORTX is on the move for good reason.I've been a long term holder in this stock because I like the story. I don't like the direction of the stock movement but thats what happens when the majority of the holders are funds that buy in and wait for management to grow the company. I've been watching the trading and noticed some selling over the last while and I've been taking advantage of someone else's situation, whatever it may be that makes them have to sell. 

So, unlike the last poster, I'm sharing the fact I've loaded up my boat after the fact!! ;-). Sorry to the seller because....

.....We are getting to a crystallization moment.

Facts

1. XORTX is meeting with the FDA May1. 

2. XORTX has completed additional steps to move into a Phase 3 program.

3. XORTX has had postive top-line results from the just completed clinical trials.

4. XORTX has submitted paperwork for the Orphan Drug Designation.

This is all the time I have today but the time is coming soon where you will look back and say, I remember when XORTX was $.60. Man I should've. Well, because I had my homework done I was able to jump in and buy when others were selling. Do yours. 

Why do I like this moment in the XORTX timeline?

This is when negotiations start to get serious with potential partners, alot of the risk has been taken off the table. WOOHOO. 

look forward to sharing comments with like shareholders!!

that is until the trolls come in to knock the price down so they can get some cheap shares. Enjoy the peace while you can!!

This is soon to be the XORTX moment!!




<< Previous
Bullboard Posts
Next >>